Oral & Salivary Cancer Biology Program

The Oral and Salivary Cancer Biology Program supports basic and translational research to improve detection and treatment of cancers of the Oral Cavity, Pharynx, and Salivary Glands. Basic research focuses on susceptibilities and mechanisms that influence tumor initiation, promotion, and progression. Translational research focuses on development of innovative biomarkers, novel diagnostic technologies, and appropriate human specimens to better characterize cancers and improve medical decision making and treatment response evaluation.

Staff Contacts

Funding Opportunity Announcements

Title Staff contact Opportunity number Activity Code Application due date
Rare Diseases Clinical Research Consortia (RDCRC) for Rare Diseases Clinical Research Network (U54 Clinical Trials Optional) RFA-TR-18-020 U54
Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed) PA-18-817 C06
Precision Imaging of Oral Lesions (R21-Clinical Trial Not Allowed) PAR-18-788 D71, R21
NIH Directors Transformative Research Award (R01 - Clinical Trial Optional) RFA-RM-18-009 D71, R01
NIH Directors New Innovator Award Program (DP2 - Clinical Trial Optional) RFA-RM-18-008 DP2
Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-18-591 C06, D43, D71
Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed) PAR-18-787 R01
Biology of Lung, and Head and Neck Preneoplasias (R21 - Clinical Trial Not Allowed) 17-460 R21
Biology of Lung, and Head and Neck Preneoplasias (R01- Clinical Trial Not Allowed) PA-17-459 R01
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional) PA-18-739 R21
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional) PA-18-738 R01
Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp) PA-18-713 C06, D43, D71
Administrative Supplement for Research on Sex/Gender Influences (Admin Supp - Clinical Trial Optional) PA-18-658 DP1, DP2, DP4
PHS 2018-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) PA-18-576 R41, R42
PHS 2018-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) PA-18-575 R41, R42
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-18-574 R43, R44
Opportunities for Collaborative Research at the NIH Clinical Center (U01 - Clinical Trial Optional) PAR-18-646 U01
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) PA-18-648 R13
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50) PAR-18-313 P50
Administrative Supplements for Research on Dietary Supplements (Admin Supp) PA-17-307 P30, P40, P50
Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional) PAR-18-009 R01
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) PAR-18-530 R01
Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed) PA-18-504 R15
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) PA-18-489 R21
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-18-484 R01
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) PAR-17-476 R01
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed) PAR-17-475 R21
SBIR Technology Transfer (R43/R44) PA-15-354 R43, R44
Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (R43/R44) PA-16-180 R43, R44
Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (R41/R42) PA-16-181 R41, R42
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44) PA-17-147 R43, R44
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) PAR-16-288 DP1, DP2, DP3
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21) PAR-17-243 R21
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01) PA-17-239 R01
Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R01) PA-16-295 R01
Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R21) PA-16-296 R21
Tools for Cell Line Identification (R43/R44) PA-16-186 R43, R44
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42) PA-17-148 R41, R42
NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03) PAR-15-344 R03
Change of Grantee Organization (Type 7 Parent) PA-16-285 C06, D43, D71
Successor-in-Interest (Type 6 Parent) PA-16-286 C06, D43, D71
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp) PA-16-289 DP1, DP2, DP3
NIDCR Small Grant Program for New Investigators (R03) PAR-16-409 R03